However, there is no difference in secretion of IL-6 in response to treatment-derived ECM, while CXCL8 only shows an increase on TGF-β1 treatment of IPF-derived ECM after three days in culture (Figure S7H). Here, CXCL8 is linked to idiopathic pulmonary fibrosis.